Page last updated: 2024-11-06

mirfentanil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Mirfentanil is a potent synthetic opioid analgesic, approximately 100 times more potent than fentanyl. It is a Schedule II controlled substance in the United States. Mirfentanil was first synthesized in 1977 and is typically administered intravenously or via nasal spray. Mirfentanil is rapidly absorbed and metabolized, resulting in a short duration of action. It is primarily used in anesthesia and pain management, particularly for procedures requiring rapid induction and short-term analgesia. It acts as a potent agonist at the mu-opioid receptor in the central nervous system, leading to analgesia, sedation, and respiratory depression. Due to its high potency and rapid onset of action, mirfentanil is often used in combination with other anesthetics, such as propofol, to facilitate rapid induction of anesthesia. Its use is closely monitored due to its potential for respiratory depression and cardiovascular effects, requiring careful patient selection and monitoring. Research into mirfentanil is ongoing, focusing on optimizing its therapeutic use, developing novel formulations, and exploring its potential for treating chronic pain.'

mirfentanil: selectively reverses the respiratory depressant effects of morphine; RN given refers to HCl; RN for parent cpd not available 9/91 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID60698
CHEMBL ID161084
SCHEMBL ID489105
MeSH IDM0188973

Synonyms (25)

Synonym
mirfentanil
L003834
a 3508
CHEMBL161084 ,
mirfentanyl
ohm 10579
furan-2-carboxylic acid (1-phenethyl-piperidin-4-yl)-pyrazin-2-yl-amide
bdbm50017404
mirfentanilum
q2u943h24p ,
mirfentanil [inn]
unii-q2u943h24p
mirfentanilum [inn-latin]
mirfentanilo [inn-spanish]
2-furancarboxamide, n-(1-(2-phenylethyl)-4-piperidinyl)-n-pyrazinyl-
117523-47-4
mirfentanilo
2-furancarboxamide, n-(1-(2-phenylethyl)-4-piperidinyl)-n-2-pyrazinyl-
ms 32 (receptor binder)
n-(1-(2-phenylethyl)-4-piperidinyl)-n-2-pyrazinyl-2-furancarboxamide
SCHEMBL489105
DTXSID10151799
DB09175
Q6873205
n-[1-(2-phenylethyl)piperidin-4-yl]-n-pyrazin-2-ylfuran-2-carboxamide

Research Excerpts

Overview

Mirfentanil is a fentanyl derivative with non-opioid actions. It has antinociceptive effects in rhesus monkeys.

ExcerptReferenceRelevance
"Mirfentanil is a fentanyl derivative with non-opioid actions, including non-opioid antinociceptive effects in rhesus monkeys. "( The rate-decreasing effects of fentanyl derivatives in pigeons before, during and after chronic morphine treatment.
Bagley, JR; Brockunier, LL; France, CP; Gauthier, CA; Gerak, LR, 1998
)
1.74
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Mu-type opioid receptorRattus norvegicus (Norway rat)Ki0.00750.00000.38458.6000AID151900
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID165439Percentage of respirations per minute after treatment with morphine when compared to control in rabbit1989Journal of medicinal chemistry, Mar, Volume: 32, Issue:3
New 4-(heteroanilido)piperidines, structurally related to the pure opioid agonist fentanyl, with agonist and/or antagonist properties.
AID129027Percentage analgesia determined by mouse hot plate assay (1 mg/kg)1989Journal of medicinal chemistry, Mar, Volume: 32, Issue:3
New 4-(heteroanilido)piperidines, structurally related to the pure opioid agonist fentanyl, with agonist and/or antagonist properties.
AID165435Percentage analgesia after treatment with compound or morphine in rabbit1989Journal of medicinal chemistry, Mar, Volume: 32, Issue:3
New 4-(heteroanilido)piperidines, structurally related to the pure opioid agonist fentanyl, with agonist and/or antagonist properties.
AID133434Analgesic activity by mouse hot plate assay at 5.01989Journal of medicinal chemistry, Mar, Volume: 32, Issue:3
New 4-(heteroanilido)piperidines, structurally related to the pure opioid agonist fentanyl, with agonist and/or antagonist properties.
AID137455Ability of compound for reversal of morphine and analgesia was determined.1989Journal of medicinal chemistry, Mar, Volume: 32, Issue:3
New 4-(heteroanilido)piperidines, structurally related to the pure opioid agonist fentanyl, with agonist and/or antagonist properties.
AID129029Percentage analgesia of determined by mouse hot plate assay (5 mg/kg)1989Journal of medicinal chemistry, Mar, Volume: 32, Issue:3
New 4-(heteroanilido)piperidines, structurally related to the pure opioid agonist fentanyl, with agonist and/or antagonist properties.
AID177773Analgesic activity by rat hot plate assay1989Journal of medicinal chemistry, Mar, Volume: 32, Issue:3
New 4-(heteroanilido)piperidines, structurally related to the pure opioid agonist fentanyl, with agonist and/or antagonist properties.
AID151900Displacement [3H]-naloxone from the Opioid receptor mu 1 isolated from rat brain membrane.1989Journal of medicinal chemistry, Mar, Volume: 32, Issue:3
New 4-(heteroanilido)piperidines, structurally related to the pure opioid agonist fentanyl, with agonist and/or antagonist properties.
AID167147Maximum pharmacological effect of compound at 0.8 cumulative dose was determined by rabbit tooth pulp assay.1989Journal of medicinal chemistry, Mar, Volume: 32, Issue:3
New 4-(heteroanilido)piperidines, structurally related to the pure opioid agonist fentanyl, with agonist and/or antagonist properties.
AID177775Analgesic activity by rat tail flick assay1989Journal of medicinal chemistry, Mar, Volume: 32, Issue:3
New 4-(heteroanilido)piperidines, structurally related to the pure opioid agonist fentanyl, with agonist and/or antagonist properties.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.69)18.7374
1990's10 (76.92)18.2507
2000's0 (0.00)29.6817
2010's1 (7.69)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (7.14%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]